Autopsy report · NCT01319045

Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease

“enrollment was too slow”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 1 year 11 months before it stopped.
• 5 participants enrolled.
• Results were posted on the registry 1 year 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of California, Los Angeles

Sponsor type

University, hospital or other

Conditions

Pulmonary Arterial Hypertension; Congenital Heart Disease; Eisenmenger's Syndrome

Interventions

Iloprost

Participants

5

Sites

1

Countries

United States

Trials that died the same way

• EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
  “too slow enrollment” (94% match in meaning)
• Frequency Specific Microcurrent for the Treatment of Diastasis Recti
  “Enrollment too slow.” (91% match in meaning)
• A Double-Blind Study on Adjunctive Use of PEMF in the Treatment of 5th Metatarsal Non-Union Fractures
  “Slow enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.